Webinars

Tutors

• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT

Aim

To provide an overview of best practice in assessing dysphagia in adult patients including the implementation of the IDSSI descriptors and how they relate to medication options. This programme will be delivered over two evenings. Part 2 will be held on Wednesday 28th September and Thursday 20th October.

Learning outcomes

Intended learning outcomes:

• Regional update on the work of Dysphagia NI
• Identify eating, drinking and swallowing difficulties
• Assess patients with swallowing difficulties, decide when Speech and Language therapy should be involved, and on whose advice should medications be changed from solid dosage forms
• Outline IDDSI descriptors and how thickeners may be used within different descriptor levels
• Utilise a stepwise approach to medication selection for patients with eating, drinking and swallowing difficulties, whilst signposting to resources to assist with this.

Tutors

• Ms Caroline Finlay
  Diabetes Specialist Nurse, NHSCT

Aim

To improve knowledge around flash and continuous blood glucose monitoring devices, equipping pharmacists to support the patient journey with novel devices and continued prescribing needs.

Learning outcomes

Intended learning outcomes:

• Awareness of the range of novel blood glucose monitoring devices and insulin pumps available
• Knowledge of how recent Guidance around devices will be implemented in NI
• Awareness of how to identify suitable patients for flash or continuous blood glucose monitoring
• Knowledge of the benefits of 24 hour monitoring outcome data and overview of sample device reports
• Awareness of insulin pumps currently utilised in NI, the criteria to qualify for this service, training & device maintenance available
• Awareness of continued prescribing needs in supporting patients with novel blood glucose monitoring devices.

Tutors

• Dr Hayley Wickens
  Consultant Pharmacist Genomic Medicine, Central and South Genomic Medicine Service
• Mrs Maire McGrady
  Regional Lead Cancer Services Pharmacist (job share), BHSCT.

Aim

To outline the potential of pharmacogenomics for more accurate and patient-tailored prescribing, across a range of common & specialist medicines to improve health outcomes.

Learning outcomes

Intended Learning Outcomes:

• Understand the concept of pharmacogenomics and how the study of patient genomes can influence medication decisions
• List the benefits of patient specific genomic information in improving medication outcomes & reducing side-effects
• List commonly prescribed medications for example antidepressants, codeine, clopidogrel & their variable patient response
• Outline current examples of drug-patient pairing using DYPD testing for cancer drugs
• Assess the impact pharmacogenomics will have on future pharmacist services.

Tutors

• Ms Nicola Maybin
  Lead Gastroenterology Pharmacist SEHSCT
• Mrs Helena Buchanan
  

Aim

To provide an overview of the differing types of inflammatory bowel disease, current best management practices and how pharmacists can contribute to supporting patients and managing inflammatory bowel disease flares.

Learning outcomes

Intended Learning Outcomes:

• Understand the pathophysiology of ulcerative colitis versus Crohns disease
• Apply an evidence-based approach to the management of inflammatory bowel disease
• Understand the mode of action of key treatment options, and their monitoring requirements, now the use of 5ASAs is not recommended
• Identify differences in budesonide licensing for differing indications
• List three ways pharmacists can support and signpost patients with inflammatory bowel disease flare ups, monitoring and side-effect management
• Evaluate case studies of successful titration & monitoring of treatment.

Tutors

• Ms Caroline Finlay
  Diabetes Specialist Nurse, NHSCT

Aim

To improve knowledge around flash and continuous blood glucose monitoring devices, equipping pharmacists to support the patient journey with novel devices and continued prescribing needs.

Learning outcomes

Intended learning outcomes:

• Awareness of the range of novel blood glucose monitoring devices and insulin pumps available
• Knowledge of how recent Guidance around devices will be implemented in NI
• Awareness of how to identify suitable patients for flash or continuous blood glucose monitoring
• Knowledge of the benefits of 24 hour monitoring outcome data and overview of sample device reports
• Awareness of insulin pumps currently utilised in NI, the criteria to qualify for this service, training & device maintenance available
• Awareness of continued prescribing needs in supporting patients with novel blood glucose monitoring devices.

Tutors

• Ms Nicola Maybin
  Lead Gastroenterology Pharmacist SEHSCT
• Mrs Helena Buchanan
  

Aim

To provide an overview of the differing types of inflammatory bowel disease, current best management practices and how pharmacists can contribute to supporting patients and managing inflammatory bowel disease flares.

Learning outcomes

Intended Learning Outcomes:

• Understand the pathophysiology of ulcerative colitis versus Crohns disease
• Apply an evidence-based approach to the management of inflammatory bowel disease
• Understand the mode of action of key treatment options, and their monitoring requirements, now the use of 5ASAs is not recommended
• Identify differences in budesonide licensing for differing indications
• List three ways pharmacists can support and signpost patients with inflammatory bowel disease flare ups, monitoring and side-effect management
• Evaluate case studies of successful titration & monitoring of treatment.

Tutors

• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT

Aim

To provide an overview of the DAMES project, as an example of a Quality Improvement project, accompanied by reflection and discussion of learnings from previous Serious Adverse Incidents to reduce the risk of further choking events, through multidisciplinary collaborative working.

Learning outcomes

Intended learning outcomes:

• Provide an overview of Dames, as an example of quality improvement projects supporting medication use for people with eating, drinking, swallowing difficulties
• Utilise learnings from local serious adverse incidents to reduce patient harm
• Multidisciplinary discussion regarding reducing the risk of further choking events through improved communication pathways.

Tutors

• Mrs Joanne Sutton
  Medicines Management Senior Technician, BHSCT.

Aim

By the development of the appropriate knowledge and skills, equip individuals to effectively mentor those pharmacy technicians undertaking the ACPT programme

Learning outcomes

Having completed this workshop you should be able to:

• provide support to pharmacy technicians regarding the knowledge and skills required to complete an accuracy check on any prescription previously screened/approved by a pharmacist
• develop your mentee's professional awareness of pharmacy practice
• encourage the further development of effective communication skills
• further develop professional relationships within your team
• support appropriate skill-mix within your pharmacy.

Tutors

• Mr Alan Wilson
  

Aim

To provide an overview of the differing types of anaemia, their identification via blood test interpretation and current best guidance for management.

Learning outcomes

Having completed this webinar you will be able to:

• Understand the differing forms of anaemia and their identification
• Improve knowledge of specific blood tests required and their interpretation
• Apply current evidence-based guidance in the management of anaemias
• Understand the various monitoring requirements and actions to take
• Evaluate case studies of successful management of anaemia and challenges overcome.

Tutors

• Mr Alan Wilson
  

Aim

To provide an overview of the differing types of anaemia, their identification via blood test interpretation and current best guidance for management.

Learning outcomes

Having completed this webinar you will be able to:

• Understand the differing forms of anaemia and their identification
• Improve knowledge of specific blood tests required and their interpretation
• Apply current evidence-based guidance in the management of anaemias
• Understand the various monitoring requirements and actions to take
• Evaluate case studies of successful management of anaemia and challenges overcome.

Tutors

• Dr Mary Larkin
  Lead Safeguarding GP Northern Ireland

Aim

To provide an overview of the range of safeguarding scenarios pharmacists may observe, and the advice, actions and assistance available to respond & care for patients effectively.

Learning outcomes

Having completed this webinar, you will have:

• Knowledge of the various forms of abuse, definitions, prevalence and healthcare professional training competencies
• Increased awareness of domestic abuse, its presentations and relevant legal frameworks
• Tools to advise domestic abuse victims appropriately, including the ‘ASK for ANI’ campaign
• Knowledge of safeguarding issues in adults at risk of harm, with case study discussion involving suspected medication misuse
• Knowledge of safeguarding policies specific to children & young people, illustrated by case study discussion
• Utilisation of the ‘Fraser Guidelines’ to assess patient capacity to understand
• Raised awareness of other emerging safeguarding themes
• Advice for pharmacists on making appropriate confidential records around safeguarding concerns.

Tutors

• Ms Jacqui Dougan
  Business Development and Leadership Consultant

Aim

To equip pharmacists with the necessary knowledge to support patients seeking advice regarding supplementation with vitamins and minerals.

Learning outcomes

Having completed this webinar you will be able to:

• Recommend special patient groups who may benefit from supplementation
• Detail various health conditions with the potential to benefit from supplementation such as arthritis
• Describe significant medication and supplement interactions
• Consider the rationale for supplement use in the management of COVID-19 related symptoms
• Provide evidence based recommendations to patients regarding supplement choice.

Tutors

• Dr Mary Larkin
  Lead Safeguarding GP Northern Ireland

Aim

To provide an overview of the range of safeguarding scenarios pharmacists may observe, and the advice, actions and assistance available to respond & care for patients effectively.

Learning outcomes

Having completed this webinar, you will have:

• Knowledge of the various forms of abuse, definitions, prevalence and healthcare professional training competencies
• Increased awareness of domestic abuse, its presentations and relevant legal frameworks
• Tools to advise domestic abuse victims appropriately, including the ‘ASK for ANI’ campaign
• Knowledge of safeguarding issues in adults at risk of harm, with case study discussion involving suspected medication misuse
• Knowledge of safeguarding policies specific to children & young people, illustrated by case study discussion
• Utilisation of the ‘Fraser Guidelines’ to assess patient capacity to understand
• Raised awareness of other emerging safeguarding themes
• Advice for pharmacists on making appropriate confidential records around safeguarding concerns.

Tutors

• Ms Jacqui Dougan
  Business Development and Leadership Consultant

Aim

To equip pharmacists with the necessary knowledge to support patients seeking advice regarding supplementation with vitamins and minerals.

Learning outcomes

Having completed this webinar you will be able to:

• Recommend special patient groups who may benefit from supplementation
• Detail various health conditions with the potential to benefit from supplementation such as arthritis
• Describe significant medication and supplement interactions
• Consider the rationale for supplement use in the management of COVID-19 related symptoms
• Provide evidence based recommendations to patients regarding supplement choice.